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Clinical and epidemiological characteristics of diarrhea associated with Vibrio mimicus were identified in 33
hospitalized patients referred to the Costa Rican National Diagnostic Laboratory Network between 1991 and
1994. The relevant symptoms presented by patients included abundant watery diarrhea, vomiting, and severe
dehydration that required intravenous Dhaka solution in 83% of patients but not fever. Seroconversion against
V. mimicus was demonstrated in four patients, from whom acute- and convalescent-phase sera were obtained.
Those sera did not show cross-reaction when tested against Vibrio cholerae O1 strain VC-12. All the V. mimicus
isolates from these cases produced cholera toxin (CT) and were susceptible to commonly used antibiotics.
Attempts to isolate this bacterium from stool samples of 127 healthy persons were not successful. Consumption
of raw turtle eggs was recalled by 11 of the 19 (58%) individuals interviewed. All but two V. mimicus diarrheal
cases were sporadic. These two had a history of a common source of turtle (Lepidochelys olivacea) eggs for
consumption, and V. mimicus was isolated from eggs from the same source (a local market). Among the strains,
variations in the antimicrobial susceptibility pattern were observed. None of the strains recovered from market
turtle eggs nor the four isolates from river water showed CT production. Further efforts to demonstrate the
presence of CT-producing V. mimicus strains in turtle eggs were made. Successful results were obtained when
nest eggs were tested. In this case, it was possible to isolate CT- and non-CT-producing strains, even from the
same egg. For CT detection we used PCR, enzyme-linked immunosorbent assay (ELISA), and Y-1 cell assay,
obtaining a 100% correlation between ELISA and PCR results. Primers Col-1 and Col-2, originally described
as specific for the V. cholerae O1 ctxA gene, also amplified a 302-bp segment with an identical restriction map
from V. mimicus. These results have important implications for epidemiological surveillance in tropical
countries where turtle eggs are used for human consumption, serving as potential sources of cholera-like diarrhea.
Aside from Vibrio choleraeO1, other bacteria have also been
implicated as etiologic agents of cholera-type diarrhea. All of
these bacteria have the ability to produce cholera toxin (CT),
the main agent responsible for the characteristic clinical pre-
sentation of the diarrhea (14, 15). With the exception of V.
cholerae O1 and V. cholerae O139, none of the vibrios have
been implicated in large outbreaks or epidemics (4). Among
these bacteria, Vibrio mimicus is a diarrhea-causing agent (10),
able to produce not only CT but also other types of toxins
which might also increase its pathogenicity (7, 8, 17, 21).
Literature on the clinical and epidemiological characteristics
of V. mimicus gastrointestinal infections is scanty. The few
clinical studies conducted in Bangladesh and the United States
reported that among the strains isolated, only 10 to 35% pro-
duced a toxin that was immunobiologically identical to the CT
of V. cholerae O1 (5, 18, 19). Nonetheless, some investigators
believe that the isolation of V. mimicus from diarrheal stools
should be regarded as potentially significant (18).
V. mimicus has also been isolated from a number of envi-
ronmental sources, including oysters, prawns, rivers, and
brackish waters (2, 5, 9, 10, 18). Nonetheless, few of those
studies have investigated the toxigenicity of these environmen-
tal strains. In Bangladesh, for example, CT production was
demonstrated only in 1% of the V. mimicus isolates from
aquatic environments (5). The significance of toxigenic envi-
ronmental strains is unknown, and specific studies are required
to elucidate their epidemiological relevance and their role in
the pathogenesis of diarrheal diseases.
In Costa Rica, the National Laboratory Network established
in 1991 the use of thiosulfate-citrate-bile salts-sucrose agar for
the routine surveillance of V. cholerae O1 in stool, water, and
food samples. Consequently, it was possible for the local lab-
oratories to recognize the presence of other vibrio species from
patients with cholera-like diarrhea. From this point on, the
National Cholera Reference Center began to receive V. mimi-
cus strains and search for environmental sources of this organ-
ism.
In this paper, we describe the clinical presentation and ep-
idemiological characteristics of V. mimicus-associated diarrhea
in Costa Rica. We also report for the first time the isolation of
V. mimicus from turtle (Lepidochelys olivacea) eggs and the
role of the eggs as a risk factor for V. mimicus diarrhea.
MATERIALS AND METHODS
Patient samples. The 33 diarrheal patients included in this study were admit-
ted to the emergency units of hospitals or clinics of the Costa Rican National
Health Security System from April 1991 to December 1994. All patients had
cholera-like diarrhea at the time of admission. The local laboratories performed
the routine stool culture, which included media for enteric pathogens, 6-h en-
richment in alkaline peptone water (pH 8.9 to 9.1), and then subculture into
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thiosulfate-citrate-bile salts-sucrose agar, following standard procedures (14, 15).
We tried to obtain acute- and convalescent-phase sera from all patients, but it
was possible to recover a second serum sample in only four cases.
Most samples were sent to the National Cholera Reference Center as isolated
V. mimicus strains for completion of biochemical identification and toxin deter-
mination and to monitor the antibiotic susceptibility pattern. Serum samples
were also referred for the serological test.
Clinical and epidemiological information was obtained through record files
and patient interviews.
Serum analysis. Agglutinating antibodies against V. mimicus were titrated by
procedures previously described for V. cholerae (1). Each patient serum sample
was titrated, in duplicate and on two different days, against the strain isolated
from its own stool sample, three V. mimicus isolates from other patients, and V.
cholerae O1 strain VC-12. Three acute- and convalescent-phase serum samples
from confirmed cholera patients were also included to determine the titer of
cross-reacting agglutinating antibodies against V. mimicus.
Normal stool samples. Stool specimens were collected from a total of 127
individuals without evidence of diarrhea within the 2 weeks before sampling.
Individuals were selected to represent the same sex, age group, and area of
residence as the diarrheal patients. These samples were analyzed by the same
procedures used for diarrheal stools (14, 15).
V. mimicus isolation from turtle eggs. The first 22 eggs (L. olivacea) analyzed
were obtained from the same shop in Cartago’s market from where two patients
with apparently independent but simultaneous cases of V. mimicus diarrhea
obtained raw eggs for consumption. The isolation of V. mimicus from these eggs
was done as follows: previously rinsed with sterile distilled water, the eggshells
were asceptically opened, and whole egg contents were homogenized in alkaline
peptone water, incubated for 6 h at 378C, and subcultured in thiosulfate-citrate-
bile salts-sucrose agar by conventional methods (13). Individual V. mimicus
colonies were subjected to toxin analysis.
In another experiment, 90 turtle eggs were sampled directly from the turtle
nests on Ostional Beach, Guanacaste, Costa Rica, because this area is the source
of most of the commercial turtle eggs in the country. An average of five V.
mimicus colonies per positive egg were independently analyzed for toxin pro-
duction, as described for the market egg samples above.
Toxigenicity assays. V. mimicus strains were studied for heat-labile CT pro-
duction by enzyme-linked immunosorbent assay (ELISA) using monoclonal an-
tibody CT-1 (CT-B), which was kindly provided by M. L. Tamplin, University of
Florida (22), and/or by the Y-1 adrenal cell assay (11). Thirty-nine isolated
strains were tested for the presence of the ctxA gene by PCR using primers Col-1
(59-CTCAGACGGGATTTGTTAGGCACG-39, positions 197 to 220) and Col-2
(59-TCTATCTCTGTAGCCCCTATTACG-39, positions 475 to 498), provided
by L. M. Sa´nchez, University of Stanford at Mexico, by the procedure described
by Shirai et al. (20). Briefly, colonies from an overnight culture on Trypticase soy
agar–1% NaCl were resuspended in 0.85% NaCl to a final concentration of
microorganisms equivalent to a McFarland no. 2 standard. Of this suspension, 1
ml was boiled for 10 min and centrifuged for 5 min at 13,6003 g. Two microliters
of the supernatant was used for PCR as described by Shirai et al. with the
following modifications: the final volume of the PCR mixture was 50 ml, no hot
start was done, the round of amplifications was repeated for 35 cycles, and we
included a final extension at 728C for 7 min. The product was visualized under
UV light after electrophoresis with molecular weight markers on a 1% agarose
gel (Sigma type IV) stained with ethidium bromide. Twenty-five microliters of
the PCR product from V. cholerae 2164-78 and 569B and from V. mimicus
SOS-471-01-94 and SOS-610-11-94 was digested for 1 h with HinfI and TaqI
(Boehringer Manheim) and DdeI (Promega), as per the manufactures’ recom-
mendations, in a total volume of 30 ml. Electrophoresis was performed on a 2%
agarose gel (Boehringer; electrophoresis grade) in Tris-borate-EDTA and visu-
alized with UV light after ethidium bromide staining. The following strains were
used as controls: toxigenic V. choleraeO1 (strains 2164-78, VC-12, and 569B) and
nontoxigenic V. cholerae O1 (strain X-316).
Antibiotic susceptibility testing. Susceptibility to nalidixic acid, amikacin, am-
picillin, chloramphenicol, doxycycline, erythromycin, furazolidone, gentamicin,
penicillin G, tetracycline, and trimethoprim-sulfamethoxazole (1.25:23.75) was
evaluated by the agar diffusion method (3). The results obtained from 28 clinical
V. mimicus strains were compared with the susceptibility patterns of 24 strains
isolated from raw turtle eggs and four from water environments.
RESULTS
From 1991 to 1994, the National Cholera Reference Center
received 33 V. mimicus isolates from the National Laboratory
Network. The sources of the isolates are shown in Table 1.
Clinical strains were obtained pure or as the predominant
bacteria from stool samples of patients who required outpa-
tient attention or were hospitalized because of the severity of
the diarrhea. The clinical presentation was characterized by
typical rice-water diarrhea (70%; one patient also had leuko-
cytes in the stool), other types of diarrhea without blood and/or
leukocytes (30%), vomiting (100%), and cramps (93%); three
of seven patients made reference to abdominal pain. None of
the patients presented fever. Eighty-three percent of them
required intravenous Dhaka solution, and 17% required oral
rehydration solutions. Among the former patients, one suf-
fered hypovolemic shock and another experienced renal fail-
ure. All patients showed a positive response to treatment with
the rehydration solutions and antibiotics conventionally used
for cholera cases.
Ninety percent of the patients were males, and 90% were
adults (above 20 years old). Cases were detected in different
geographic regions of Costa Rica; only seven came from coun-
ties next to the coast, but none of those patients had a history
of recent contact with seawater. Furthermore, V. mimicus was
not found in any of the stool samples of 127 individuals without
symptoms of diarrhea during the previous 2 weeks.
The serological analysis of the acute- and convalescent-
phase sera from four V. mimicus diarrheal patients demon-
strated an increase in the agglutinating antibodies when ti-
trated against the strain isolated from their own fecal samples,
while titers against V. cholerae O1 strain VC-12 remained ,1:
40. V. mimicus agglutinating antibodies were also measured in
four convalescent-phase serum samples from confirmed chol-
era cases with vibriocidal antibody titers of .1:640 against V.
cholerae O1 strain VC-12. All of these sera gave titers below
1:40 against V. mimicus (data not shown).
We were able to interview 19 V. mimicus diarrheal patients.
Eleven (58%) recalled eating raw turtle eggs within a week
before the onset of the diarrhea. The same question was of-
fered to 74 persons without diarrhea, matched by age group,
sex, and area of residence. Among them, only two persons
(3%) gave an affirmative answer. Other possible sources of
infection were investigated, especially with regard to the inges-
tion of raw seafood (fish, shrimp, and bivalves). Although these
sea products are commonly consumed by Costa Ricans, a clear
difference in the frequency of consumption (within 1 week
before the interview) was not observed between the group of
people who suffered V. mimicus diarrhea and the group with-
out diarrhea.
All but two cases of V. mimicus diarrhea were sporadic. The
two patients involved had history of a common source of turtle
TABLE 1. Detection of CT in V. mimicus strains by Y-1 cell assay,
PCR, and ELISA
Source of strain
No. of CT-positive strains/total no.
analyzed by:
Y-1 cell assay
ctxA PCR ELISAa
CyTb CyLc
Human (diarrheal stool) 2/2 26/26 15/15 25/25
River water 0/2 2/4 0/4 0/4
Turtle eggs
Cartago’s market 1/11 2/12 0/8 0/12
Ostional Beach NDd ND 6/12 ND
Reference strains V. cholerae O1
2164-78 1 2 1 1
569B 1 2 ND 1
VC-12 ND ND 1 ND
X-316 2 2 2 2
a Using anti-CT-B class I monoclonal antibody.
b CyT, cytotoxic activity. 1, more than 10% rounded cells per well. This effect
could not be evaluated in 24 human, 2 river, and 7 turtle egg strains because of
the presence of a strong cytolytic activity effect.
c CyL, cytolytic activity. 1, 50% or more dead, lysed, and/or detached cells.
d ND, not done.
1142 CAMPOS ET AL. APPL. ENVIRON. MICROBIOL.
eggs for consumption. In 22 eggs sampled from the same
source (Cartago’s market), 4 were positive for V. mimicus and
12 individual isolates were obtained.
Regardless of origin of isolation, all V. mimicus strains were
resistant to penicillin G and susceptible to nalidixic acid, chlor-
amphenicol, furazolidone, gentamicin, tetracycline, and tri-
methoprim-sulfamethoxazole. None of the isolates from hu-
mans showed resistance to doxycycline, amikacin, ampicillin,
or erythromycin; of the 24 isolates from eggs, 25% were am-
picillin resistant and 4% were erythromycin resistant; and of
the four strains from water, three were doxycycline resistant,
two were ampicillin resistant, and one was amikacin resistant.
All V. mimicus clinical strains exhibit CT production. In
contrast, none of the 4 isolates from river water nor any of the
12 isolates from turtle eggs from Cartago’s market produced
CT (Table 1). From the turtle eggs obtained directly from the
nests at Ostional Beach, toxigenic and nontoxigenic V. mimicus
strains were successfully recovered. As shown in Table 1, CT
detection by the Y-1 cell assay was not always possible because
of the strong cytolytic effects of the supernatants. This effect
was more commonly observed among the isolates from hu-
mans.
PCR of V. mimicus and V. cholerae DNA with Col-1 and
Col-2 primers amplified products of identical size (302 bp).
The restriction patterns of these products were also identical.
TaqI gave fragments of 241 and 60 bp, HinfI gave fragments of
211 and 90 bp, and DdeI gave fragments of 233 and 68 bp (data
not shown). There were no discrepancies between PCR and
ELISA results for the 20 V. mimicus strains analyzed by both
techniques.
DISCUSSION
Even though V. mimicus has been documented as responsi-
ble for various types of gastrointestinal and extraintestinal hu-
man illness, little is known about its clinical presentation (10,
18, 19). There is epidemiological evidence pointing to an en-
vironmental origin for these infections, but no previous studies
have been able to isolate toxigenic V. mimicus from the sus-
pected foods (19). Investigations searching for possible sources
of V. mimicus infection have been conducted in different coun-
tries, including Costa Rica, and have found this bacterium in a
variety of aquatic environments, such as seafood (like fish,
shrimp, and bivalves), freshwater, brackish water, seawater,
mud samples, and water plants (2, 9, 10, 23).
It has been shown that some V. mimicus strains are able to
produce a heat-labile enterotoxin, functionally and immuno-
biologically related to the heat-labile CT (12, 22), as well as
other toxins and toxic substances that might contribute to its
pathogenesis (5, 7, 8, 12). Nevertheless, as in the case of V.
choleraeO1, CT is probably the main factor responsible for the
severity of this diarrhea.
Publications from Bangladesh, Calcutta (India), and the
United States reported that only 10 to 35% of the V. mimicus
found in clinical specimens produced CT. These data may
explain why most of the patients studied (60 to 80%) presented
a mild form of diarrhea and were attended as outpatients,
treated only with oral rehydration solutions (18, 19). In con-
trast, all the patients that we studied were hospitalized as
suspected cholera cases, 83% of them requiring intravenous
rehydration. All the strains derived from these patients were
CT producers. This high occurrence of CT-producing strains is
similar to the results obtained from a collection of eight clinical
isolates referred from Bangladesh (12).
The investigation of CT production from clinical strains was
difficult using the Y-1 assay, because all cell-free supernatants
had cytolytic activity. Therefore, we used the PCR and ELISA
techniques to identify the CT-positive strains. For PCR, we
used the Col-1 and Col-2 primers, because although they were
originally described as specific for V. cholerae O1 ctxA (20), we
could obtain a 302-bp product from V. mimicus which had a
restriction pattern identical to the ctxA product of V. cholerae,
according to the sequence published by Mekalanos et al. (16).
Even more, the results from ELISA and PCR were always in
agreement (Table 1). Therefore, PCR using Col-1 and Col-2 is
not specific for V. cholerae CT, as originally described by Shirai
et al. (20), and should not be used as the only means for V.
cholerae O1 detection in food and environmental samples.
In Costa Rica, the majority of the patients identified with V.
mimicus diarrhea were adult males, differing from the pattern
in Bangladesh, where no specific sex or age distribution was
observed (18). As described in the literature, these diarrheas
appeared sporadically and no secondary cases were observed
(18, 19).
When patients in this study were asked about suspected
seafood consumption, 58% recalled the ingestion of raw turtle
eggs within the week before the onset of illness. In Costa Rica,
there are several beach areas for turtle nesting sites and turtle
eggs are traditionally served in cantinas as a complement of
alcoholic beverages. This practice is more common among
adult males and could explain, at least in part, the sex and age
distribution that we found. For these reasons, we also investi-
gated the frequency of consumption of raw turtle eggs among
healthy people with similar characteristics. We found that al-
though this is a traditional food, only 3% of the informants
without diarrhea consumed this product during the week be-
fore the interview. Also, none of 127 stool samples from adults
without diarrhea was positive for V. mimicus. On the basis of
these observations and the occurrence of two simultaneous V.
mimicus cases in which the patients recalled consumption of
turtle eggs from the same market shop, turtle eggs were sam-
pled, and from them it was possible to demonstrate the pres-
ence of V. mimicus. Furthermore, it was also interesting that
among V. mimicus diarrheal cases, three were children. From
two of them there was no information about ingestion of sus-
pected foods. Parents from the third child recalled that al-
though she did not eat turtle eggs, she was playing with them
within the week before the onset of diarrhea.
When we studied the toxigenicity of strains obtained from
turtle eggs, we isolated CT- and non-CT-producing strains,
even from the same egg. In contrast to clinical isolates, it was
rare to find cytolytic activity in the cell-free supernatants. Four
isolates from river water showed cytolytic activity, but none
produced CT. Previous studies have also shown that very few
(1%) of the environmental V. mimicus isolates were CT posi-
tive (5, 23). Although CT is probably the main toxin responsi-
ble for the cholera-type diarrhea, the significance of isolating
non-CT-producing strains from diarrheal patients in other
studies merits further investigation concerning the presence of
other toxins.
With regard to antimicrobial susceptibility patterns, the clin-
ical isolates of V. mimicus were all susceptible to conventional
antibiotics used for cholera patients, in accord with observa-
tions made in other countries (6, 18). Although the excretion
of viable cells was not evaluated after the onset of therapy,
some patients continued with diarrhea 2 to 3 days after initi-
ation of the specific chemotherapy, suggesting a behavior sim-
ilar to the CT effect in cholera. Among environmental strains,
the ones isolated from river water presented variations in the
antibiotic susceptibility patterns, similar to the findings of
Chowdhury et al. (6).
Since there have been no previous studies on the serological
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reactions of patients with V. mimicus diarrhea, the microag-
glutination technique for V. cholerae O1 was adapted and used
to evaluate seroconversion in four patients. With this tech-
nique it was possible to demonstrate specific seroconversion
against V. mimicus, and no significant cross-reaction with V.
cholerae O1 strain VC-12 was observed. This seroconversion
supports the role of the V. mimicus isolates as etiologic agents
of diarrhea. Further serological and toxigenic characterization
of the clinical and environmental isolates might contribute to
the understanding of the possible association of those features
with the clinical presentation, source of isolation, and geo-
graphical distribution of this pathogen.
This is the first report of the isolation of V. mimicus from
turtle eggs. Our findings strongly suggest the role of these eggs
as vehicles for acquiring V. mimicus diarrhea. The sources of V.
mimicus turtle egg contamination and the kinds of toxins
present in these bacterial strains are under current investiga-
tion.
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